摘要
目的分析冠心病心力衰竭患者实施美托洛尔缓释片联合曲美他嗪疗法的效果。方法该研究100例冠心病心力衰竭患者从该院2012年6月—2015年12月方便抽选,按抽样法将其分成两组:对照组患者采取基础疗法+美托洛尔缓释片疗法,为50例;研究组患者于对照组基础上加用曲美他嗪疗法,为50例,评定疾病治疗后的效果。结果研究组病症缓解48例,占比96.0%;对照组病症缓解40例,占比50.0%,P<0.05,差异有统计学意义。结论临床针对冠心病心力衰竭患者实施美托洛尔缓释片联合曲美他嗪疗法作用突出,可改善患者心功能,增强疗效,值得借鉴。
Objective To analyze the implementation of metoprolol in patients with coronary heart disease combined with sustained-release tablets trimetazidine effect triazine therapy. Methods Convenient selection the 100 cases of coronary heart disease patients with heart failure from our hospital in June 2012 to December 2015 lottery, according to the sampling method will divided into two groups： control group patients were treated with basic therapy ＋ metoprolol sustained-release tablets therapy, 50 cases; study group patients than the control group on the basis of the trimetazidine therapy and in 50 cases, after treatment of disease assessment results. Results The study group of disease remission in 48 cases, accounting for 96%; the control group of disease remission in 40 cases, accounting for 50%, P〈0.05, there is a difference.Conclusion The clinical heart failure in patients with coronary heart disease for the implementation of joint sustained-release tablets of metoprolol trimetazidine therapy prominent role, can improve cardiac function, enhance the effect, it is worth learning from.
出处
《中外医疗》
2016年第23期119-121,共3页
China & Foreign Medical Treatment
关键词
美托洛尔缓释片
曲美他嗪
冠心病
心力衰竭
应用效果
Metoprolol sustained-release tablets
Trimetazidine
Coronary heart disease
Heart failure
Application effect
